IMCC ▾TradingView OVTLYR console News (1w)Earnings search — IM Cannabis Corp. Common Shares

Healthcare · ETF XLV · as of 2026-09-18

Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ

IM Cannabis Corp. Common Shares XNAS

Healthcare · Drug Manufacturers - Specialty & Generic

Market cap

P/E (TTM)

EPS (TTM)

-75.27

Employees

IPO

Website

Price & today

$4.23 ATR(14) — (—%)

Stock today	+143.10%
Sector ETF today	-0.25%
Residual (stock-specific)	+143.35%

Sector correlation

20-day correlation with XLV	-0.05
60-day correlation with XLV	-0.07
Status	normal

Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.

Technicals

10 EMA	$—
20 EMA	$—
50 EMA	$—
EMA stack	UNKNOWN
RSI(14)	—
52-week high distance	-94.51%
52-week low distance	+172.90%

Signals

Market F&G	45.6
Bull%	12.2%
OVTLYR status	—
Sector rank	—
Next earnings	—

TradingView OVTLYR console More news (Google) Sector dashboard (XLV)

MarketSmith metrics - our compute

RS Rating

ADR%

22.6

RMV (tight)

100.0

Ext (ATR>20EMA)

Rel Vol

4718.0%

U/D 50d

22.26

U/D 25d

47.69

Accum/Dist 25d

4 / 3

EPS YoY

LoD dist

Off 52w High

94.5%

Above 52w Low

172.9%

1W / 1M

+141.7 / +33.0

Avg $Vol 50d

9.3M

Mkt Cap (B)

0.0

Trend 8/8

Sector XLV

+1.8% 1W

not available: eps_history(<5 quarters), revenue(no EDGAR qtrs=1 fact)

What do these abbreviations mean?

RS Rating: - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
ADR%: - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
RMV (tight): - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
Ext (ATR>20EMA): - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
Rel Vol: - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
U/D 50d / 25d: - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
Accum/Dist 25d: - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
LoD dist: - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
Off/Above 52w: - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
Trend 8/8: - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
Base len (VCP): - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.

Fundamentals & valuation - reference, not entry inputs

P/E (TTM)

Fwd P/E

PEG

Price/Book

Profit margin

-39.1%

ROE

Debt/Equity

Rev growth

-40.2%

Analyst target

Analyst rating

NONE

Institutional %

1.9%

Insider %

11.8%

Float %

79.5%

Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.

Company data - context read, not entry inputs

Industry rank

16 / 147

Industry

Drug Manufacturers - Specialty & Generic

Float

0.5M

Float turnover 20d

1111.2%

Avg $Vol 20d / 50d

22.4M / 9.3M

Days to cover

0.1

Short % float

2.2%